ENIPMA


  • Home
  • About Us
  • Alternative Energy
    • Bioenergy
      • Solar Power
        • Nuclear Energy
          • Wind Energy
            • Carbon Emissions
            • Social Network
              • Users
                • Content
                  • Systems
                  • Medicine
                    • Biologics
                      • Medical Devices
                        • Medical Services
                        • Others
                          • Economy
                          • Entrée
                          • Contact Us

                                   Contact Us

                          Chinese
                                                     
                                        ENIPMA LLP

                                        (Reg. no. T09LL1084A)

                                        111 North Bridge Road
                                        #05-32 Peninsula Plaza
                                        Singapore 179098

                                        Tel     : +65 8388 8253
                                        Email : mail@enipma.com



                          We are happy to assist you in conducting targeted competitive technology analyses.
                          All inquiries and feedback are welcome and will be kept strictly confidential.

                          Picture

                          EnIPma

                          EnIPma

                          EnIPma Genentech's 2nd phase III study showed Lucentis improved vision in patients with central retinal vein occlusion http://bit.ly/RbkGb 3 hours ago reply

                          EnIPma 454 Life Sciences, Roche Nimblegen, Eli Lilly & SeqWright collaborate to identify psychiatric disease biomarkers http://bit.ly/10xEfQ 2 hours ago reply

                          Join the conversation


                          Copyright © 2010-2011 ENIPMA

                          All Rights Reserved